Shivalik Rasayan Ltd

₹ 756 16.67%

03 Jul - close price

shivalikrasayan.com BSE: 539148 NSE: SHIVALIK

About

The company is into manufacturing of agrochemicals and in 2015 it forayed into pharmaceuticals.
The company acquired Medicamen Biotech Limited in 2015 which is engaged in manufacturing pharmaceutical formulations. ^[1] ^[2]

Key Points

Business Segments
Shivalik Rasayan is into 2 business segments :

Website BSE NSE

Market Cap ₹ 1,179 Cr.
Current Price ₹ 756
High / Low ₹ 893 / 493
Stock P/E 72.1
Book Value ₹ 326
Dividend Yield 0.07 %
ROCE 5.80 %
ROE 3.77 %
Face Value ₹ 5.00

Add ratio to table

Edit ratios

Pros

Cons

The company has delivered a poor sales growth of 9.87% over past five years.
Company has a low return on equity of 6.38% over last 3 years.
Dividend payout has been low at 3.66% of profits over last 3 years
Promoter holding has decreased over last 3 years: -4.97%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Agro Chemicals Industry: Pesticides / Agrochemicals - Indian

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
	43.32	50.39	56.69	59.53	48.14	57.83	56.33	57.36	62.93	64.47	67.05	70.23	71.23
	32.36	37.86	44.69	47.60	37.84	45.99	45.32	47.38	52.81	53.10	57.39	61.37	61.94
Operating Profit	10.96	12.53	12.00	11.93	10.30	11.84	11.01	9.98	10.12	11.37	9.66	8.86	9.29
OPM %	25.30%	24.87%	21.17%	20.04%	21.40%	20.47%	19.55%	17.40%	16.08%	17.64%	14.41%	12.62%	13.04%
	0.55	0.08	0.48	1.30	1.85	1.45	0.85	1.46	0.90	0.42	0.56	1.50	1.49
Interest	0.50	0.36	0.52	0.74	0.89	1.03	0.88	1.07	1.36	1.47	1.96	1.58	2.61
Depreciation	2.11	2.60	2.64	2.92	2.85	3.01	2.83	2.95	2.81	2.81	3.44	3.01	3.11
Profit before tax	8.90	9.65	9.32	9.57	8.41	9.25	8.15	7.42	6.85	7.51	4.82	5.77	5.06
Tax %	4.49%	5.28%	7.62%	12.64%	3.09%	8.54%	6.26%	10.24%	-3.21%	13.72%	45.02%	24.78%	9.09%
	8.50	9.14	8.61	8.37	8.14	8.46	7.65	6.65	7.08	6.48	2.65	4.34	4.60
EPS in Rs	4.77	4.88	4.44	4.28	4.51	4.40	3.82	3.27	2.28	2.80	1.21	1.97	2.21
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
	41	110	123	155	171	186	198	215	234	273
	38	99	105	131	147	157	159	167	191	234
Operating Profit	3	10	18	24	24	29	38	47	43	39
OPM %	7%	9%	15%	16%	14%	16%	19%	22%	19%	14%
	0	1	1	3	8	3	1	4	5	4
Interest	0	5	6	4	3	2	2	3	5	8
Depreciation	0	2	2	2	3	4	9	11	12	12
Profit before tax	3	5	11	20	26	27	29	37	32	23
Tax %	33%	33%	25%	25%	20%	17%	15%	7%	6%	22%
	2	3	8	15	21	22	25	34	30	18
EPS in Rs	2.10	3.66	9.84	14.39	9.88	10.17	12.77	17.68	14.66	10.51
Dividend Payout %	0%	0%	4%	3%	5%	2%	4%	3%	3%	5%

Compounded Sales Growth
10 Years:	%
5 Years:	10%
3 Years:	11%
TTM:	16%

Compounded Profit Growth
10 Years:	%
5 Years:	4%
3 Years:	-2%
TTM:	-23%

Stock Price CAGR
10 Years:	%
5 Years:	24%
3 Years:	-1%
1 Year:	-3%

Return on Equity
10 Years:	%
5 Years:	7%
3 Years:	6%
Last Year:	4%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	3	3	3	4	7	7	7	7	7	8
Reserves	8	11	7	45	158	169	172	280	353	500
	0	31	32	22	20	10	29	38	58	76
	11	36	52	81	103	142	155	163	160	109
Total Liabilities	23	81	94	152	288	328	363	488	578	692
	7	27	27	40	41	52	210	221	218	214
CWIP	0	0	0	0	26	102	0	3	57	117
Investments	0	0	0	0	0	0	0	0	0	0
	16	53	66	111	222	175	153	264	303	362
Total Assets	23	81	94	152	288	328	363	488	578	692

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
	4	12	8	-7	-8	6	59	11	-19	-6
	-0	-18	-4	-24	-24	-102	-65	-23	-71	-86
	1	3	-3	52	100	10	2	78	50	99
Net Cash Flow	4	-3	2	21	69	-86	-4	66	-40	7

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	80	77	92	108	111	114	127	119	132	116
Inventory Days	5	64	76	65	71	65	34	148	239	266
Days Payable	126	152	137	103	123	171	152	216	208	136
Cash Conversion Cycle	-41	-11	31	71	59	7	9	51	162	245
Working Capital Days	-11	36	52	107	147	160	98	146	206	200
ROCE %		32%	32%	28%	16%	11%	11%	12%	8%

Shareholding Pattern

Numbers in percentages

3 Recently

	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
	52.92%	52.92%	50.32%	50.32%	50.32%	50.32%	50.32%	50.32%	50.05%	47.95%	47.95%	47.95%
	0.00%	0.00%	0.00%	0.06%	0.04%	0.01%	0.01%	0.01%	0.35%	0.66%	1.18%	2.99%
	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.24%	0.59%	0.88%
	47.08%	47.08%	49.68%	49.62%	49.64%	49.67%	49.67%	49.67%	49.60%	51.14%	50.28%	48.17%
No. of Shareholders	6,199	7,401	7,790	7,792	7,726	8,380	8,579	8,460	8,556	9,190	9,149	9,398

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
	71.20%	62.62%	52.50%	52.92%	52.92%	50.32%	50.32%	47.95%
	0.00%	0.00%	0.04%	0.00%	0.00%	0.06%	0.01%	2.99%
	1.84%	0.41%	0.00%	0.00%	0.00%	0.00%	0.00%	0.88%
	26.96%	36.97%	47.46%	47.08%	47.08%	49.62%	49.67%	48.17%
No. of Shareholders	1,419	2,227	3,038	3,350	5,549	7,792	8,460	9,398

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

All

Annual reports

Concalls

Dec 2021

Transcript

Notes
PPT
Sep 2021

Transcript

Notes
PPT
Aug 2020

Transcript

Notes
PPT
Dec 2019

Transcript

Notes
PPT
Dec 2019

Transcript

Notes
PPT